Routine Use of Continuous, Hyperfractionated, Accelerated Radiotherapy for Non-Small-Cell Lung Cancer: A Five-Center Experience

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 716-722

  Din, Omar S ^a   Lester, Jason ^b   Cameron, Alison ^b   Ironside, Janet ^c   Gee, Amanda ^d   Falk, Stephen ^d   Morgan, Sally A ^e   Worvill, Jackie ^e   Hatton, Matthew Q F ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^e NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Acceleration; CHART; Continuous hyperfractionated accelerated radiotherapy; Hyperfractionation; Non small cell lung cancer; Radiotherapy

Indexed keywords

ELECTROTHERAPEUTICS; PATIENT MONITORING; PATIENT TREATMENT; RADIOTHERAPY; STANDARDS; TOXICITY;

ACCELERATED RADIOTHERAPY; ACCELERATION; CHART; CLINICAL PRACTICES; CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY; DATA COLLECTIONS; HYPERFRACTIONATION; MEDIAN SURVIVAL; NON-SMALL CELL LUNG CANCER; PERFORMANCE STATUS; RANDOMIZED TRIAL; SURVIVAL RATES; UNITED KINGDOM;

BIOLOGICAL ORGANS;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL RATE; TREATMENT FAILURE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; SURVIVORS;

EID: 52949085771     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.033     Document Type: Article

References (27)

1. Stewart BW KPE. World Cancer Report. Geneva: IARC Press; 2003.
2. In: Toms J.R. (Ed). CancerStat Monograph 2004 (2004), Cancer Research UK, London
3. Sause W.T. The role of radiotherapy in non-small cell lung cancer. Chest 116 (1999) 504S-508S
4. Perez C.A., Stanley K., Rubin P., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group. Cancer 45 (1980) 2744-2753
5. Saunders M., Dische S., Barrett A., et al., CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. Lancet 350 (1997) 161-165
6. National Collaborating Centre for Acute Care. The diagnosis and treatment of lung cancer. London: National Collaborating Centre for Acute Care. Available from: www.rcseng.ac.uk. Accessed May 4, 2007.
7. Saunders M., Dische S., Barrett A., et al., CHART Steering Committee. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. Radiother Oncol 52 (1999) 137-148
8. Ghosh S., Sujendran V., Alexiou C., et al. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancer. Eur J Cardiothorac Surg 24 (2003) 1002-1007
9. Jenkins P., D'Amico K., Benstead K., et al. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART). Int J Radiat Oncol Biol Phys 56 (2003) 360-366
10. Clenton S.J., Fisher P.M., Conway J., et al. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 17 (2005) 599-603
11. McGibney C., Holmberg O., McClean B., et al. Dose escalation of chart in non-small-cell lung cancer: Is three-dimensional conformal radiation therapy really necessary?. Int J Radiat Oncol Biol Phys 45 (1999) 339-350
12. Belani C.P., Wang W., Johnson D.H., et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. J Clin Oncol 23 (2005) 3760-3767
13. Baumann M., Herrmann T., Koch R., et al. Continuous hyperfractionated accelerated radiotherapy-weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): First results of a phase III randomised multicentre trial (ARO 971). [Abstract]. Eur J Cancer S3 (2005) 322
14. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study. J Clin Oncol 23 (2005) 5910-5917
15. Curran W.J., Scott C.B., and LAnger C.J. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. [Abstract]. Proc Am Soc Clin Oncol 22 (2003) 621
16. Sause W., Kolesar P., Taylor S.I., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
17. Huber R.M., Flentje M., Schmidt M., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 24 (2006) 4397-4404
18. Belani C.P., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
19. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 46 (2004) 87-98
20. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
21. Oral E.N., Bavbek S., Kizir A., et al. Preliminary analysis of a phase II study of paclitaxel and CHART in locally advanced non-small cell lung cancer. Lung Cancer 25 (1999) 191-198
22. Oral E.N. Long term results of CHART and weekly paclitaxel in locally advanced non-small cell lung cancer. Lung Cancer 49 (2005) 421-422
23. Kirkbride P., Hatton M., Lorigan P., et al. Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer. Clin Oncol (R Coll Radiol) 14 (2002) 361-366
24. Oner-Dincbas F, Koca S, Altinel A. CHART plus chemotherapy with vinorelbine and cisplatinum in locally advanced NSCLC. Proceedings of the European Cancer Organization, 2001. p. a184.
25. Hatton M. INCH: A randomised phase II/III trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy (CHART) versus CHART alone in patients with inoperable non-small cell lung cancer: Medical Research Council (MRC) Trial Number LU23; 2004.
26. Hanna N.H., Neubauer M.M., Ansari R., et al. Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023. Proceedings of the ASCO Annual Meeting, Part I. [Abstract]. J Clin Oncol 25 (2007) 7512
27. Gandara D.R., Chansky K., Albain K.S., et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 21 (2003) 2004-2010